Coincidence Technologies is now part of GE Medical Systems, and Kretztechnik is within a hair of joining it. Belgium-based Coincidence Technologies brings to GE technology for efficient manufacture of the PET radiopharmaceutical fluorodeoxyglucose (FDG)
Coincidence Technologies is now part of GE Medical Systems, and Kretztechnik is within a hair of joining it. Belgium-based Coincidence Technologies brings to GE technology for efficient manufacture of the PET radiopharmaceutical fluorodeoxyglucose (FDG) (SCAN 9/5/01). A synthesizer is used in conjunction with a cyclotron, providing the final chemical steps in producing the FDG. Austria-based Kretztechnik develops 3-D ultrasound systems. GE has acquired the 65.4% of Kretztechnik shares held by Medison, as well as another 27.1% of the company’s outstanding shares. These transactions provide GE with 92.5% ownership in Kretztechnik. After GE acquires the remaining shares, Kretztechnik will become a wholly owned subsidiary.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Reducing the Interval Breast Cancer Rate of Screening DBT: Can AI Have an Impact?
July 29th 2025In a retrospective review of screening digital breast tomosynthesis (DBT) exams for over 200 women with interval breast cancers, researchers found that AI provided accurate localization of cancers in 32.6 percent of the cases.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.